IL166102A0 - Beta-sheet breaking peptides and their use - Google Patents

Beta-sheet breaking peptides and their use

Info

Publication number
IL166102A0
IL166102A0 IL16610205A IL16610205A IL166102A0 IL 166102 A0 IL166102 A0 IL 166102A0 IL 16610205 A IL16610205 A IL 16610205A IL 16610205 A IL16610205 A IL 16610205A IL 166102 A0 IL166102 A0 IL 166102A0
Authority
IL
Israel
Prior art keywords
beta
sheet breaking
peptides
breaking peptides
sheet
Prior art date
Application number
IL16610205A
Other languages
English (en)
Original Assignee
Applied Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Res filed Critical Applied Res
Publication of IL166102A0 publication Critical patent/IL166102A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Biochemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Vascular Medicine (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL16610205A 2002-07-08 2005-01-03 Beta-sheet breaking peptides and their use IL166102A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02100787 2002-07-08
EP02102834 2002-12-19
PCT/EP2003/050287 WO2004005336A2 (en) 2002-07-08 2003-07-07 β-SHEET BREAKING PEPTIDES

Publications (1)

Publication Number Publication Date
IL166102A0 true IL166102A0 (en) 2006-01-15

Family

ID=30116915

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16610205A IL166102A0 (en) 2002-07-08 2005-01-03 Beta-sheet breaking peptides and their use

Country Status (7)

Country Link
EP (1) EP1532170A2 (xx)
JP (1) JP2006508904A (xx)
AU (1) AU2003271745A1 (xx)
CA (1) CA2489754A1 (xx)
IL (1) IL166102A0 (xx)
NO (1) NO20050436D0 (xx)
WO (1) WO2004005336A2 (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130065042A1 (en) 2011-03-11 2013-03-14 The Board Of Trustees Of The University Of Illinois Micro-Vascular Materials And Composites For Forming The Materials
SG187271A1 (en) * 2011-07-07 2013-02-28 Agency Science Tech & Res Anti-amyloidogenic, alpha-helix breaking ultra-small peptide therapeutic

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9917724D0 (en) * 1999-07-28 1999-09-29 Medical Res Council Peptides
KR20060133114A (ko) * 1999-11-05 2006-12-22 액소닉스, 인코포레이티드. 아밀로이드, 아밀로이드-유사 침착물, 또는 β-쉬이트가풍부한 그의 병리학적 전구체로의 비정상적 단백질 폴딩과관련된 질환의 치료에 있어서 생체내에서 사용하기에적합한 펩티드 동족체 및 유사체

Also Published As

Publication number Publication date
NO20050436L (no) 2005-01-26
NO20050436D0 (no) 2005-01-26
CA2489754A1 (en) 2004-01-15
JP2006508904A (ja) 2006-03-16
WO2004005336A2 (en) 2004-01-15
AU2003271745A1 (en) 2004-01-23
EP1532170A2 (en) 2005-05-25
WO2004005336A3 (en) 2004-02-26

Similar Documents

Publication Publication Date Title
AU2003267124A8 (en) Bh3 peptides and method of use thereof
EP1539941A4 (en) ADZYMES AND THEIR USES
EP1419175A4 (en) PEPTIDES OF REPLIKIN AND THEIR USE
EP1414848A4 (en) REPLICINE PEPTIDES AND ITS USES
AU2003211163A8 (en) Partial peptide mimetics and methods
IL165112A0 (en) Variant integrinpolypeptides and thereof
AU2003226899A8 (en) Human diabetes-mediating proteins
GB0309064D0 (en) Modified peptides and their uses
AU2003231827A8 (en) Pseudo-tissues and uses thereof
HK1209050A1 (en) Survivin-derived peptides and use thereof
IL166102A0 (en) Beta-sheet breaking peptides and their use
EP1487459A4 (en) PEPTIDE ANALOGUES AND USES
EP1577322A4 (en) NEW PROTEINS AND THEIR USE
EP1541677A4 (en) NEW PROTEINS AND USE THEREOF
GB0202275D0 (en) Peptide
EP1699809A4 (en) PEPTIDE FROM AMNIOTIC LIQUID AND USES THEREOF
TW553468U (en) Plate-spring and micro-actuating switch of the same
GB0223860D0 (en) Polypeptide methods and means
GB0222255D0 (en) Peptides and their use
EP1395276A4 (en) STRUCTURALLY MODIFIED PEPTIDES AND THEIR USE
GB0210746D0 (en) Peptide
AU2003216442A8 (en) Enkurin and uses thereof
IL149179A0 (en) FcyRII-BINDING PEPTIDES AND USES THEREOF
AU2003953561A0 (en) Peptides and therapeutic uses thereof
AU2003265814A8 (en) Aw755252-interacting proteins and use thereof